+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skyrizi Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103911
The skyrizi market research report is one of a series of new reports that provides skyrizi market statistics, including skyrizi industry global market size, regional shares, competitors with a skyrizi market share, detailed skyrizi market segments, market trends and opportunities, and any further data you may need to thrive in the skyrizi industry. This skyrizi market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growth in the forecast period can be attributed to growing adoption in psoriasis, increasing number of patients, growing geriatric population, increasing awareness and improved diagnosis, and increased consumption of processed foods. Major trends in the forecast period include technological innovations in biologics, a shift toward combination therapies, advancements in diagnostic technologies, a shift from oral to injectable treatments, and artificial intelligence (AI) for drug development.

The increasing prevalence of psoriasis is expected to drive the growth of the Skyrizi market. Psoriasis is a chronic autoimmune condition that leads to the rapid buildup of skin cells, causing scaling on the skin's surface. Factors such as genetic predisposition, environmental triggers, greater awareness, improved diagnosis rates, lifestyle changes, and the rising impact of stress and immune-related disorders contribute to the growing prevalence of psoriasis. Skyrizi, a biologic therapy that targets interleukin-23 (IL-23), treats psoriasis by blocking this cytokine, which plays a crucial role in the inflammatory process. This reduces skin inflammation, alleviates symptoms such as redness and scaling, and improves overall skin clearance in patients with moderate to severe plaque psoriasis. For example, the National Psoriasis Foundation reported in December 2022 that around 8 million Americans and 125 million people worldwide have psoriasis, with 30% of them also developing psoriatic arthritis. As the prevalence of psoriasis increases, the demand for Skyrizi is expected to rise.

The growing interest in personalized medicine is anticipated to further fuel the growth of the Skyrizi market. Personalized medicine is an approach that tailors treatments and healthcare strategies to the individual characteristics of each patient, including their genetic makeup, environment, and lifestyle, to achieve the most effective outcomes. The rising adoption of personalized medicine is driven by advancements in genomics, an improved understanding of molecular biology, the availability of precision diagnostic tools, and the demand for targeted therapies that enhance patient outcomes and minimize side effects. Skyrizi supports personalized medicine by providing a biologic therapy that specifically inhibits IL-23, allowing healthcare providers to tailor treatments for patients with moderate to severe autoimmune diseases such as psoriasis and ulcerative colitis. This targeted approach improves treatment efficacy while minimizing side effects. In 2023, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from the six approvals in 2022. As the focus on personalized medicine grows, the Skyrizi market is expected to expand.

The key trend in the skyrizi market is the expansion of its therapeutic indications, such as for ulcerative colitis (UC), which enhances treatment options for autoimmune diseases. Skyrizi has been approved for the treatment of moderate-to-severe UC, showing promising clinical improvements in patients who have not responded to other therapies. For example, in July 2024, AbbVie received approval from the European Commission for Skyrizi to treat adult patients with moderately to severely active UC who have not responded to or are intolerant of conventional or biologic therapies. This approval followed positive results from Phase 3 trials, including INSPIRE and COMMAND, which demonstrated mucosal healing in patients who had not previously used biologic or JAK inhibitor therapies. Skyrizi’s dosing regimen includes a 1,200 mg induction dose followed by maintenance doses of 180 mg or 360 mg every 8 weeks. This expansion of indications offers new hope for UC patients who have not found success with conventional treatments.

The key company operating in the skyrizi market is AbbVie Inc.

North America was the largest region in the skyrizi market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in skyrizi report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the skyrizi market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Skyrizi is a prescription medication used to treat certain autoimmune conditions, including moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease, by reducing inflammation in the body. The mechanism of action of Skyrizi (risankizumab-rzaa) involves selectively targeting and inhibiting interleukin-23 (IL-23), a protein that plays a key role in inflammatory and immune responses.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for skyrizi include plaque psoriasis, Crohn's disease, and ulcerative colitis. Plaque psoriasis is a common form of psoriasis characterized by raised, red patches covered with silvery-white scales, typically appearing on the scalp, elbows, and knees. This condition causes discomfort and irritation for affected individuals. Skyrizi is available in formulations such as pre-filled syringes and vials and is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The skyrizi market consists of sales of intravenous (IV) infusion for induction and subcutaneous (SC) injection and pen injectors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Skyrizi Market Characteristics
3. Skyrizi Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Skyrizi Market Trends And Strategies5. Skyrizi Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global Skyrizi Growth Analysis And Strategic Analysis Framework
6.1. Global Skyrizi PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Skyrizi Market Growth Rate Analysis
6.4. Global Skyrizi Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Skyrizi Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Skyrizi Total Addressable Market (TAM)
7. Global Skyrizi Pricing Analysis & Forecasts
8. Skyrizi Market Segmentation
8.1. Global Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Plaque Psoriasis
  • Crohn's Disease
  • Ulcerative Colitis
8.2. Global Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Pre-Filled Syringes
  • Vials
8.3. Global Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
9. Global Skyrizi Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Skyrizi Market Regional And Country Analysis
10.1. Global Skyrizi Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Skyrizi Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Skyrizi Market
11.1. Asia-Pacific Skyrizi Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Skyrizi Market
12.1. China Skyrizi Market Overview
12.2. China Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Skyrizi Market
13.1. India Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Skyrizi Market
14.1. Japan Skyrizi Market Overview
14.2. Japan Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Skyrizi Market
15.1. Australia Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Skyrizi Market
16.1. South Korea Skyrizi Market Overview
16.2. South Korea Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Skyrizi Market
17.1. Western Europe Skyrizi Market Overview
17.2. Western Europe Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Skyrizi Market
18.1. UK Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Skyrizi Market
19.1. Germany Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Skyrizi Market
20.1. France Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Skyrizi Market
21.1. Eastern Europe Skyrizi Market Overview
21.2. Eastern Europe Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Skyrizi Market
22.1. North America Skyrizi Market Overview
22.2. North America Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Skyrizi Market
23.1. USA Skyrizi Market Overview
23.2. USA Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Skyrizi Market
24.1. Canada Skyrizi Market Overview
24.2. Canada Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Skyrizi Market
25.1. South America Skyrizi Market Overview
25.2. South America Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Skyrizi Market
26.1. Middle East Skyrizi Market Overview
26.2. Middle East Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Skyrizi Market
27.1. Africa Skyrizi Market Overview
27.2. Africa Skyrizi Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Skyrizi Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Skyrizi Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Skyrizi Market Competitive Landscape And Company Profiles
28.1. Skyrizi Market Competitive Landscape
28.2. Skyrizi Market Company Profiles
28.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Skyrizi Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Skyrizi Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Skyrizi Market32. Recent Developments In The Skyrizi Market
33. Skyrizi Market High Potential Countries, Segments and Strategies
33.1 Skyrizi Market In 2029 - Countries Offering Most New Opportunities
33.2 Skyrizi Market In 2029 - Segments Offering Most New Opportunities
33.3 Skyrizi Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

Skyrizi Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on skyrizi market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for skyrizi ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The skyrizi market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Indication: Plaque Psoriasis; Crohn's Disease; Ulcerative Colitis
2) By Formulation: Pre-Filled Syringes; Vials
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Key Companies Profiled: AbbVie Inc.

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • AbbVie Inc.